IL-35在免疫相关疾病中的研究进展

被引:4
作者
王志会
机构
[1] 三峡大学第二临床学院检验科
关键词
白细胞介素-35; 自身免疫疾病; 肿瘤;
D O I
暂无
中图分类号
R593 [免疫性疾病];
学科分类号
100201 [内科学];
摘要
<正>白细胞介素-35(IL-35)是白细胞介素-12(IL-12)家族的新成员,由Collison等[1]在2007年最先发现并确认。IL-12家族共有4个成员,分别为:IL-12、IL-23、IL-27、IL-35。这4种细胞因子均为异质二聚体,每1个异质二聚体细胞因子均由1个折叠螺旋束样细胞因子(four helix bundle cytokines)亚单位(IL-12p35、IL-23p19、IL-27p28、IL-35p35)和1个可溶型细胞因子受体样亚单位(p40和EBl3)组成(图1)[2]。1 IL-35及其家族成员受体IL-12受体为IL-12Rβ1/IL-12Rβ2二聚体,2个
引用
收藏
页码:239 / 242
页数:4
相关论文
共 8 条
[1]
IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells.[J].Jun Long;Xulong Zhang;Mingjie Wen;Qingli Kong;Zhe Lv;Yunqing An;Xiao-Qing Wei.Biochemical and Biophysical Research Communications.2012,
[2]
IL-35 production by inducible costimulator (ICOS)–positive regulatory T cells reverses established IL-17–dependent allergic airways disease.[J].Gregory S. Whitehead;Rhonda H. Wilson;Keiko Nakano;Lauranell H. Burch;Hideki Nakano;Donald N. Cook.The Journal of Allergy and Clinical Immunology.2011, 1
[3]
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis.[J].Stefan Wirtz;Ulrike Billmeier;Tamuna Mchedlidze;Richard S. Blumberg;Markus F. Neurath.Gastroenterology.2011, 5
[4]
Detectable expression of IL-35 in CD4 + T cells from peripheral blood of chronic Hepatitis B patients.[J].Fen Liu;Fuyi Tong;Yan He;Haiyan Liu.Clinical Immunology.2010, 1
[5]
Analysis of Interleukin-27 (EBI3/p28) Expression in Epstein-Barr Virus- and Human T-Cell Leukemia Virus Type 1-Associated Lymphomas.[J].Frédérique Larousserie;Emilie Bardel;Stefan Pflanz;Bertrand Arnulf;Carmen Lome-Maldonado;Olivier Hermine;Laurence Brégeaud;Monique Perennec;Nicole Brousse;Rob Kastelein;Odile Devergne.The American Journal of Pathology.2005, 4
[6]
The role of T lymphocytes in the pathogenesis of asthma [J].
Larché, M ;
Robinson, DS ;
Kay, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (03) :450-463
[7]
Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[8]
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils; airway hyper-responsìveness; and the late asthmatic response.[J].Margaret J Leckie;Anneke ten Brinke;Jamey Khan;Zuzana Diamant;Brian J O'Connor;Christine M Walls;Ashwini K Mathur;Hugh C Cowley;K Fan Chung;Ratko Djukanovic;Trevor T Hansel;Stephen T Holgate;Peter J Sterk;Peter J Barnes.The Lancet.2000, 9248